Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.omkarpharmachem.co.in | |
Market Cap | 22.67 Cr. | |
Enterprise Value(EV) | 23.16 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.20 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 115.08 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 9.17 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.45 | Calculated using Price: 22.48 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.01 Cr. | 10,084,800 Shares |
FaceValue | 10 | |
About Omkar Pharmachem Ltd. | ||
The company is engaged in the manufacturing of pharmaceutical chemicals. |
1 Day |
|
|
1 Week |
|
|
1 Month |
|
+4.56% |
3 Month |
|
+3.21% |
6 Month |
|
+8.08% |
1 Year |
|
-10.08% |
2 Year |
|
+6.29% |
5 Year |
|
+75.62% |
10 Year |
|
+288.26% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -0.66 | -1.27 | 2.38 | -2.77 | -4.72 | -3.03 | 2.59 | 2.09 | 2.21 | |
Return on Capital Employed (%) | -0.66 | -1.27 | 2.91 | -2.55 | -4.11 | -2.22 | 0.22 | 2.76 | 3.2 | |
Return on Assets (%) | -0.65 | -1.22 | 2.3 | -2.72 | -4.49 | -2.78 | 2.36 | 1.93 | 2.06 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Curr. Liab. | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | |
Non Curr. Assets | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | |
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 1 | 1 | 1 | ||||||
Other Income | 0 | ||||||||||
Total Income | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Depreciation | |||||||||||
Taxation | 0 | 0 | 0 | 0 | 0 | ||||||
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | ||||||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 27 Mar 2024
Closure of Trading Window Dear Sir Pursuant to SEBI (Prohibition of Insider Trading Regulations) 2015 as amended and in compliance with the terms of Code of conduct of the company please note that the Trading window for dealing in shares of the company will remain closed for the designated persons and their immediate relatives from Monday 01st April 2024 till the completion of 48 hrs after the date of declaration of Audited financial results of the company for quarter and year ended on 31.03.2024. |
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Dear Sir Please find News papers publication of Quarter and Nine months ended as on 31st December 2023 |
Wed, 14 Feb 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2024 Dear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 14th February 2024 has considered and approved the following business:Unaudited Financial Results of the Company along with Limited Review Report for the Quarter and Nine Months ended on 31st December 2023. |
No Scans Found |